Definiens

Do you want to understand how #artificialintelligence can support #patient profiling in #precisiononcology. Download your free chapter of Tissue Phenomics here! bit.ly/2UwGZqQ

Why #AI-powered Biomarker Analysis is the Future of #Cancer Immune Profiling. Checkpoint inhibitors in #immunotherapy are a major medical breakthrough but scientists & doctors must use AI-powered biomarker analysis for better #immuneprofiling. bit.ly/30L9Udd

Researchers characterize lung inflammation associated with some cancer #immunotherapy: Findings might help predict who will react poorly to certain therapies sciencedaily.com/releases/2019/…

Here's Dr. Andreas Spitzmueller yesterday at #WCLC2019 with his poster: Tumor Proliferation Associated with #Tumor Immunological Status: Study of NSCLC Using Multiplex Immunofluorescence. Thanks to everyone who came by yesterday! wclc2019.iaslc.org

Do you want to understand how #artificialintelligence can support #patient profiling in #precisiononcology. Download your free chapter of Tissue Phenomics here! bit.ly/2ZMu0Gw

Please join us at @HISTALIM -Multiplex Histopathology Annual Meeting- in Montpellier Sept.12, 2019. Dr. Florian Leiss & Dr. Ana Hidalgo-Sastre will discuss multiplex digital imaging and patient #immuneprofiling! #immunotherapy bit.ly/30T8LAg

See you at @IASLC #WCLC19 in Barcelona this weekend! Please join Dr. Andreas Spitzmueller for his poster presentation: Tumor Proliferation Associated with #Tumor Immunological Status: Study of NSCLC Using Multiplex Immunofluorescence. bit.ly/2UBSc9M

Have you read our latest newsletter yet? Don't miss out - find out about our FREE upcoming events before #SITC19, #ESMO19, and meet us at World CB & CDx! Read it here: bit.ly/30S6ipz #immunotherapy #immunoOncology #biomarkers

See you at @IASLC #WCLC19 in Barcelona this weekend! Please join Dr. Andreas Spitzmueller for his poster presentation: Tumor Proliferation Associated with #Tumor Immunological Status: Study of NSCLC Using Multiplex Immunofluorescence. bit.ly/2ZIYJo6

#FridayFacts #immunotherapy #DYK- Did you know: mIHC/IF is the most accurate approach in predicting response to anti-PD-1/PD-L1 therapy? Check out this meta-study to compare here: jamanetwork.com/journals/jamao…

During #SITC2019's Workshop on Intratumoral Immunomodulation, the current status of intratumoral immunomodulation will be presented and future directions for the field will be discussed, along with implications for immunotherapy treatments. sitcancer.org/2019/program/p…

Congratulations @DendreonNews! Largest Real Word Evidence Suggest 4 year #Survival Benefit in #ProstateCancer With #PROVENGE @ThePCRC @PCFnews @ZEROCancer #CRPC #mCRPC #PCSM #immunotherapy #GUcancer #sipleucel theoncoforum.com/largest-real-w…

Attending @HISTALIM -Multiplex Histopathology Annual Meeting- in Montpellier Sept.12, 2019? Please join Dr. Florian Leiss & Dr. Ana Hidalgo-Sastre, who will discuss multiplex digital imaging and patient #immuneprofiling! #immunotherapy bit.ly/2ZFcfsQ

Have you read our latest newsletter yet? Don't miss out - find out about our FREE upcoming events before #SITC19, #ESMO19, and meet us at World CB & CDx! Read it here: bit.ly/30RKkmR #immunotherapy #immunoOncology #biomarkers

Why #AI-powered Biomarker Analysis is the Future of #Cancer Immune Profiling. Checkpoint inhibitors in #immunotherapy are a major medical breakthrough but scientists & doctors must use AI-powered biomarker analysis for better #immuneprofiling. bit.ly/2ZEpOsy